RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
EVENT
EMA Methodology Working Party interested parties meeting 2026
Published: 11/4/2026Detected: 10/23/2026

Summary preview

Fosters stakeholder exchange with the EMA Methodology Working Party on emerging methods across biostatistics, modelling, simulation, pharmacogenomics, data science and AI.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
clinical
safety
labeling
manufacturing
quality
#EMA
#biostatistics
#modelling
#simulation
#pharmacogenomics

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • EMA paediatric investigation plans in-person training course11/5/2026
  • Committee for Advanced Therapies (CAT): 4-6 November 202611/4/2026
  • eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course for sponsors - November 202611/3/2026
  • Committee for Orphan Medicinal Products (COMP): 3-5 November 202611/3/2026
  • Committee for Medicinal Products for Veterinary Use (CVMP): 3-5 November 202611/3/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.